Sernova and Seraxis plan merger to form BetaNova Biotherapeutics
Sernova and Seraxis plan to merge their type 1 diabetes islet cell replacement programs into BetaNova Biotherapeutics in 2026.
Image modified: Seraxis
Sanofi launches COVID-19 campaign with USA Pickleball
Sanofi and USA Pickleball launch a US campaign to educate older adults about COVID-19 risks and the vaccine NUVAXOVID.
Takeda announces planned retirement of R&D chief Andy Plump
Takeda says R&D chief Andy Plump will retire in June 2027, with a successor process and transition planned as the late-stage pipeline advances.
Hovione appoints Stefan Doboczky as CEO
Hovione appoints Stefan Doboczky as CEO. The board chair will take operational charge of the pharma technology group in April 2027.
UCB presents epilepsy art initiative at EEC 2026
UCB launched Expressing Epilepsy at the European Epilepsy Congress in Athens, presenting works by three artists living with epilepsy.
Jenny Blum joins BVMed as sustainability officer
Jenny Blum has joined BVMed as sustainability officer. The former DIN team coordinator will cover ESG topics and standardisation processes.
STADA appoints Diana Wiedmann as Chief Culture & People Officer
Diana Wiedmann will become STADA’s Chief Culture & People Officer on 1 January 2027, succeeding Simone Berger in the role.
AstraZeneca uses AI llama for new Breztri campaign
AstraZeneca promotes Breztri with an AI-generated llama, using humor and a LAMA wordplay to explain the triple therapy.
Lonza Appoints Samanta Cimitan as Chief Commercial Officer
Lonza has created a Chief Commercial Officer role and appointed Samanta Cimitan, who is set to join the CDMO by early 2027.
HAL Allergy and InfectoPharm partner on ENT DiGAs
HAL Allergy and InfectoPharm have formed a multi-year DiGA partnership. The first focus is Meine Tinnitus App for ENT practices in Germany.